相关实验视频
Updated: May 5, 2026
07:29
Programmed Electrical Stimulation in Mice
Published on: May 27, 2010
20.3K
提摩西综合征中的前节律缺陷需要卡尔莫杜林酶II
William H Thiel1, Biyi Chen, Thomas J Hund
1Vanderbilt University, Nashville, TN, USA.
Circulation
|November 13, 2008
概括
蒂莫西综合征 (TS) 失常症源于由于Ca(V) 1.2突变而导致的过度摄入. 这项研究表明,由突变引发的CaMKII激活是由突变引发的.
科学领域:
- 心血管生理学心血管生理学
- 分子心脏病学分子心脏病学
- 心脏电生理学 心脏电生理学
背景情况:
- 蒂莫西综合征 (TS) 的特征是细胞 (Ca2+) 的过度进入和危及生命的心律失常.
- 这种情况是由心脏L型Ca2+通道 (CaV1.2) 的突变引起的,导致正常电压依赖性失活的丧失.
- 在细胞Ca2+过载期间的卡尔莫杜林依赖蛋白激酶II (CaMKII) 激活与TS节律失常有关.
研究的目的:
- 研究CaMKII在提摩西综合征的前节律机制中的作用.
- 开发和利用TS的老鼠心室肌细胞模型来研究CaV1.2通道功能和CaMKII活性.
- 阐明上游事件导致TS中的心律失常表型.
主要方法:
- 开发了一个成年大鼠心室肌细胞模型的TS (G406R) 使用lentivirus介导转移突变的CaV1.2.2.
- 利用一种抗二皮里丁的CaV1.2突变 (T1066Y) 来选择性地研究外源道功能.
- 采用Ca2+缓冲条件和生理Ca2+解决方案来评估CaMKII激活和前节律事件.
- 用 CaMKII 抑制来评估其对细胞电生理学的影响.
- 开发了一种修订后的数学模型,包含了CaMKII依赖和独立的效应.
主要成果:
- 表达TS CaV1.2的肌细胞显示了电压依赖性失活的损失,并在生理Ca2+中增加了CaMKII活性.
- 观察到的前节律表型包括动作潜力的延长,增加ICa促进和脱极化后.
- 抑制CaMKII可以逆转ICa促进,使作用潜能正常化,并防止后分极化.
- 为了解释CaMKII的作用,开发了一种修订后的数学模型.
结论:
- 在TS中失去电压依赖性失活是心律失常的起始事件.
- CaMKII激活是TS相关的前节律表型的关键下游调解者.
- 了解这种途径对于开发提摩西综合征的治疗策略至关重要.
相关概念视频
01:16Calmodulin-dependent Signaling
5.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
01:28Mechanism of Cardiac Arrhythmias
2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
01:29Disturbances in Heart Rhythm
5.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K
01:15Dysrhythmias I: Introduction
730
Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
730
01:25Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597